Suppr超能文献

支气管源性癌中细胞学检查阴性的胸腔积液的意义。

The significance of a cytologically negative pleural effusion in bronchogenic carcinoma.

作者信息

Decker D A, Dines D E, Payne W S, Bernatz P E, Pairolero P C

出版信息

Chest. 1978 Dec;74(6):640-2. doi: 10.1378/chest.74.6.640.

Abstract

Bronchogenic carcinoma complicated by ipsilateral cytologically positive effusion is considered unresectable. Bronchogenic carcinoma with cytologically negative effusion, even if bloody, has also been thought by many to be unresectable. Seventy-three patients with bronchogenic carcinoma and ipsilateral cytologically negative effusions were studied. Sixty-six underwent exploratory thoracotomy for staging or therapy; five had pleural biopsies and two had mediastinoscopies, all disclosing metastatic carcinoma. Four of the 73 patients (5.5 percent) had surgically resectable disease. They have remained free of disease for 3, 6, 7, and 14 years. Sixty-nine patients (94.5 percent) had unresectable carcinoma with metastases. Seventeen (94 percent) of 18 patients with bloody effusions had unresectable cancer. Carcinoma was resected in one patient with cytologically negative bloody effusion, and the patient remained free of disease during the 14-year follow-up period. Unresectability must be documented surgically in these patients to exclude those in whom curative resection can be performed.

摘要

合并同侧细胞学检查阳性胸腔积液的支气管源性癌被认为不可切除。许多人也认为,即使胸腔积液为血性,但细胞学检查阴性的支气管源性癌也不可切除。对73例患有支气管源性癌且同侧胸腔积液细胞学检查阴性的患者进行了研究。66例患者接受了开胸探查以进行分期或治疗;5例进行了胸膜活检,2例进行了纵隔镜检查,所有检查均发现有转移性癌。73例患者中有4例(5.5%)患有可手术切除的疾病。他们分别已无疾病生存3年、6年、7年和14年。69例患者(94.5%)患有不可切除的转移性癌。18例血性胸腔积液患者中有17例(94%)患有不可切除的癌症。1例胸腔积液细胞学检查阴性且为血性的患者接受了癌切除术,在14年的随访期内该患者一直无疾病生存。对于这些患者,必须通过手术记录其不可切除性,以排除那些可进行根治性切除的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验